Modern approaches to the choice of schemes for eradication of Helicobacter рylori infection (based on the materials of the consensus meeting "Maastricht-VI")

Abstract

The article presents an analysis of the provisions of the consensus meeting “Maastricht-VI”, dedicated to the treatment of Helicobacter pylori (H. pylori) infection. The expediency of preliminary testing for H. pylori sensitivity to antibiotics is emphasized. Since this strategy has not yet been implemented in everyday clinical practice, empirical therapy is often carried out based on the results of the assessment of H. pylori resistance to antibiotics in this region. The sequence of administration of eradication regimens of the 1st, 2nd, 3rd, 4th lines, optimal duration of treatment, new therapy regimens (with rifabutin, double therapy with proton pump inhibitors and amoxicillin in high doses) are considered. The implementation of the new consensus meeting will contribute to improving the results of eradication therapy of H. pylori infection.